Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall AntiLambda APCH7

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 2 Device Recall AntiLambda APCH7 see related information
Date Initiated by Firm December 19, 2014
Date Posted January 20, 2015
Recall Status1 Terminated 3 on March 11, 2016
Recall Number Z-1002-2015
Recall Event ID 70106
Product Classification Reagents,specific,analyte - Product Code MVU
Product Anti-Lambda APC-H7, Catalog Number 656157.


Product Usage:
Intended for in vitro flow cytometric immunophenotyping of hematologic disorders.
Code Information Lot numbers 4155632 with expiry date of 2015-06-30.  Lot 42889687 was not shipped to customers.
Recalling Firm/
Manufacturer		 BD Biosciences, Systems & Reagents
2350 Qume Dr
San Jose CA 95131-1812
For Additional Information Contact Eric Claussen
408-954-6348
Manufacturer Reason
for Recall		 Two lots of the Anti-Lambda APC-H7 antibody are contaminated with CD38 antibody.
FDA Determined
Cause 2		 Vendor change control
Action BD sent a Recall notification letters dated December, 2014 to affected customers via Certified mail. The letter identified the affected product, problem and actions to be taken. Customers were instructed to inspect inventory for affected lots, immediately remove affected reagents from their laboratory, request replacement product and complete and return the enclosed Tracking/Verification form, per the instructions. For questions contact BD Customer Support at 855-236-2772.
Quantity in Commerce 15 units
Distribution US Nationwide Distribution in the states of CA, NY, and MI
Total Product Life Cycle TPLC Device Report
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-